Sex differences in autoimmune disease from a pathological perspective

American Journal of Pathology

Volumn 173, Issue 3, 2008, Pages 600-609

  Fairweather, Delisa ^a,c   Frisancho Kiss, Sylvia ^a   Rose, Noel R ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c The Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ACUTE DISEASE; AGE; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHRONIC DISEASE; DISEASE SEVERITY; FEMALE; FIBROSIS; GENDER; GRAVES DISEASE; HUMAN; INCIDENCE; INFECTION; INFLAMMATION; INJURY; MALE; NEUTROPHIL CHEMOTAXIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL; VACCINATION;

EID: 51349089115     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.071008     Document Type: Review

References (118)

1. Progress in Autoimmune Diseases Research, Report to Congress, National Institutes of Health, The Autoimmune Diseases Coordinating Committee, March 2005
2. Jacobson DL, Gange SJ, Rose NR, Graham NMH: Epidemiology and estimated population burden of selected autoimmune disease in the United States. Clin Immunol Immunopathol 1997, 84:223-243
3. Dooley MA, Hogan SL: Environmental epidemiology and risk factors for autoimmune disease. Curr Opin Rheumatol 2003, 15:99-103
4. Gleicher N, Barad DH: Gender as risk factor for autoimmune diseases. J Autoimmun 2007, 28:1-6
5. Styrt B, Sugarman B: Estrogens and infection. Rev Infect Dis 1991, 13:1139-1150
6. Girón-González JA, Moral FJ, Elvira J, Garcia-Gil D, Guerrero F, Gavilan I, Escobar L: Consistent production of a higher Th1:Th2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000, 143:31-36
7. Klein SL: The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 2000, 24:627-638
8. Lang TJ: Estrogen as an immunomodulator. Clin Immunol 2004, 113:224-230
9. Kher A, Wang M, Tsai BM, Pitcher JM, Greenbaum ES, Nagy RD, Patel KM, Wairiuko GM, Markel TA, Meldrum DR: Sex differences in the myocardial inflammatory response to acute injury. Shock 2005, 23:1-10
10. Straub RH: The complex role of estrogens in inflammation. Endocrine Rev 2007, 28:521-574
11. Fairweather, D: Autoimmune disease: mechanisms. Encyclopedia of Life Sciences. Chichester, John Wiley & Sons Ltd., 2007 DOI: 10.1002/ 9780470015902.a0020193
12. Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H: Autoreactivity in human IgG+ memory B cells. Immunity 2007, 26:205-213
13. Notkins AL: Pathogenic mechanisms in autoimmune disease. Autoimmun Rev 2004, 3(Suppl 1): S7-S9
14. Wilder RL: Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995, 13:307-338
15. Fairweather D, Rose NR: Immunopathogenesis of autoimmune disease. Immunotoxicology and Immunopharmacology, ed 3. Edited by Luebke R, House R, Kimber I. Boca Raton, CRC Press, 2007, pp 423-436
16. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, Gatewood SJL, Rose NR: IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-γ and macrophage and neutrophil populations in the heart. J Immunol 2005, 174:261-269
17. Stockinger B, Veldhoen M, Martin B: Th17 T cells: linking innate and adaptive immunity. Semin Immunol 2007, 19:353-361
18. Matsuzaki G, Umemura M: Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007, 51:1139-1147
19. Pappu BP, Angkasekwinai P, Dong C: Regulatory mechanisms of helper T cell differentiation: new lessons learned from interleukin 17 family cytokines. Pharmacol Ther 2008, 117:374-384
20. Annacker O, Burlen-Defranoux O, Pimenta-Araujo R, Cumano A, Bandeira A: Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment. J Immunol 2000, 164:3573-3580
21. Stockinger B, Veldhoen M: Differentiation and function of Th17 T cells. Curr Opin Immunol 2007, 19:281-286
22. Raimondi G, Turner MS, Thomson AW, Morel PA: Naturally occurring regulatory T cells: recent insights in health and disease. Crit Rev Immunol 2007, 27:61-95
23. Fairweather D, Yusung S, Frisancho-Kiss S, Barrett M, Gatewood S, Steele R, Rose NR: IL-12Rβ1 and TLR4 increase IL-1β and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 2003, 170:4731-4737
24. Fairweather D, Frisancho-Kiss S, Rose NR: Viruses as adjuvants for autoimmunity: evidence from coxsackievirus-induced myocarditis. Rev Med Virol 2005, 15:17-27
25. Morwood SR, Nicholson LB: Modulation of the immune response by extracellular matrix proteins. Arch Immunol Ther Exp 2006, 54:367-374
26. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM: Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007, 7:1271-1285
27. van Duin D, Medzhitov R, Shaw AC: Triggering TLR signaling in vaccination. Trends Immunol 2006, 27:49-55
28. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 2006, 124:783-801
29. Frisancho-Kiss S, Nyland JF, Davis SE, Frisancho JA, Barrett MA, Rose NR, Fairweather D: Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rβ1 signaling and IFN-γ increase inflammation in males independent from STAT4. Brain Res 2006, 1126:139-147
30. Fremond CM, Togbe D, Doz E, Rose S, Vasseur V, Maillet I, Jacobs M, Ryffel B, Quesniaux VF: IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J Immunol 2007, 179:1178-1189
31. Leber JH, Crimmins GT, Raghavan S, Meyer-Morse NP, Cox JS, Portnoy DA: Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog 2008, 4:e6
32. Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Rose NR, Fairweather D: Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 2007, 178:6710-6714
33. Frisancho-Kiss S, Nyland JF, Davis SE, Barrett MA, Gatewood SJL, Njoku DB, Cihakova D, Silbergeld EK, Rose NR, Fairweather D: Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 2006, 176:6411-6415
34. Karin M, Lawrence T, Nizet V: Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124:823-835
35. Meyers JH, Sabatos CA, Chakravarti S, Kuchroo VK: The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med 2005, 11:362-369
36. Sun J, Walsh M, Villarino AV, Cervi L, Hunter CA, Choi Y, Pearce EJ: TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J Immunol 2005, 174:742-751
37. Dillon S, Agrawal A, van Dyke T, Landreth G, McCauley L, Koh A, Maliszewski C, Akira S, Pulendran B: A Toll-like receptor 2 ligand stimulates Th2 responses in vivo via induction of extracellular signalregulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 2004, 172:4733-4743
38. Re F, Strominger JL: IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 2004, 173:7548-7555
39. Imanishi T, Hara H, Suzuki S, Suzuki N, Akira S, Saito T: Cutting edge: TLR2 directly triggers Th1 effector functions. J Immunol 2007, 178:6715-6719
40. Jones B, Chen J: Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J 2006, 25:2443-2452
41. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM: Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 2007, 8:145-153
42. Kumar V, Abbas AK, Fausto N (Eds): Acute and chronic inflammation. Robbins and Cotran Pathologic Basis of Disease, ed 7. Philadelphia, Elsevier Saunders, 2005, pp 47-86
43. 1. IL-1β, and IL-4 in the heart. Am J Pathol 2004, 165:1883-1894
44. Kumar V, Abbas AK, Fausto N (Eds): Tissue renewal and repair: regeneration, healing and fibrosis. Robbins and Cotran Pathologic Basis of Disease, ed 7. Philadelphia, Elsevier Saunders, 2005, pp 87-118
45. Lane JR, Neumann DA, Lafond-Walker A, Herskovitz A, Rose NR: Interleukin 1 or tumor necrosis factor can promote coxsackievirus B3-induced myocarditis in resistant B10 A mice. J Exp Med 1992, 175:1123-1129
46. Ito A, Bebo Jr BF, Matejuk A, Zamora A, Silverman M, Fyfe-Johnson A, Offner H: Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 2001, 167:542-552
47. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR: From infection to autoimmunity. J Autoimmun 2001, 16:175-186
48. Fairweather D, Rose NR: Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 2007, 41:118-122
49. Rose NR, Mackay IR (Eds): The Autoimmune Diseases, ed 4. St. Louis, Elsevier Academic Press, 2006
50. Kumar V, Abbas AK, Fausto N (Eds): Robbins and Cotran Pathologic Basis of Disease, ed 7. Philadelphia, Elsevier Saunders, 2005
51. Verthelyi D, Klinman DM: Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo. Immunology 2000, 100:384-390
52. Beeson PB: Age and sex associations of 40 autoimmune diseases. Am J Med 1994, 96:457-462
53. Lopez AD: Global and regional burden of disease and risk factors, 2001: systemic analysis of population health data. Lancet 2006, 367:1747-1757
54. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005, 6:1245-1252
55. Whitacre CC: Sex differences in autoimmune disease. Nat Immunol 2001, 2:777-780
56. Fairweather D, Rose NR: Women and autoimmune diseases. Emerg Infect Dis 2004, 10:2005-2011
57. Zandman-Goddard G, Peeva E, Shoenfeld Y: Gender and autoimmunity. Autoimmun Rev 2007, 6:366-372
58. Kublickiene K, Luksha L: Gender and the endothelium. Pharmacol Rep 2008, 60:49-60
59. Karpuzoglu-Sahin E, Hissong BD, Ahmed SA: Interferon-γ levels are upregulated by 17-β-estradiol and diethylstilbestrol. J Reprod Immunol 2001, 52:113-127
60. Dimayuga FO, Reed JL, Carnero GA, Wang C, Dimayuga ER, Dimayuga VM, Perger A, Wilson ME, Keller JN, Bruce-Keller AJ: Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. J Neuroimmunol 2005, 161:123-136
61. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, Offner H: Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004, 173:2227-2230
62. Polanczyk MJ, Hopke C, Huan J, Vandenbark AA, Ziegler SF, Offner H: Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol 2005, 170:85-92
63. Evans MJ, Eckert A, Lai K, Adelman SJ, Harnish DC: Reciprocal antagonism between estrogen receptor and NF-κB activity in vivo. Circ Res 2001, 89:823-830
64. Demyanets S, Pfaffenberger S, Kaun C, Rega G, Speidl WS, Kastl SP, Weiss TW, Hohensinner PJ, Dietrich W, Tschugguel W, Bochkov VN, Awad EM, Maurer G, Huber K, Wojta J: The estrogen metabolite 17b-dihydroequilenin counteracts interleukin-1α induced expression of inflammatory mediators in human endothelial cells in vitro via NF-κB pathway. Thromb Haemost 2006, 95:107-116
65. Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE: Oestrogen signaling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 2007, 9:470-478
66. Feldman I, Feldman GM, Mobarak C, Dunkelberg JC, Leslie KK: Identification of proteins within the nuclear factor-kappa B transcriptional complex including estrogen receptor-alpha. Am J Obstet Gynecol 2007, 196:394.e1-394.e11
67. Paimela T, Ryhanen T, Mannermaa E, Ojala J, Kalesnykas G, Salminen A, Kaarniranta K: The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells. Immunol Lett 2007, 110:139-144
68. Liu H-B, Loo KK, Palaszynski K, Ashouri J, Lubahn DB, Voskuhl RR: Estrogen receptor α mediates estrogen's immune protection in autoimmune disease. J Immunol 2003, 171:6936-6940
69. Palaszynski K, Liu H-B, Loo KK, Voskuhl RR: Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 2004, 149:84-89
70. Gharaee-Kermani M, Hatano K, Nozaki Y, Phan SH: Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol 2005, 166:1593-1606
71. Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ: In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 2000, 85:1648-1657
72. Klein SL, Bird BH, Glass GE: Sex differences in immune responses and viral shedding following Seoul virus infection in Norway rats. Am J Trop Med Hyg 2001, 65:57-63
73. Loria RM: Immune up-regulation and tumor apoptosis by androstene steroids. Steroids 2002, 67:953-966
74. Desai KV, Michalowska AM, Kondaiah P, Ward JM, Shih JH, Green JE: Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate. Mol Endocrinol 2004, 18:2895-2907
75. Wang M, Tsai BM, Kher A, Baker LB, Wairiuko GM, Meldrum DR: Role of endogenous testosterone in myocardial proinflammatory and proaptotic signaling after acute ischemia-reperfusion. Am J Physiol 2005, 288:H221-H226
76. Palaszynski K, Loo KK, Ahouri JF, Liu H-B, Voskuhl RR: Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 2004, 146:144-152
77. Mendelsohn ME, Karas RH: Molecular and cellular basis of cardiovascular gender differences. Science 2005, 308:1583-1587
78. Ogawa S, Chester AE, Hewitt SC, Walker VR, Gustafsson J-A, Smithies O, Korach KS, Pfaff DW: Abolition of male sexual behaviors in mice lacking estrogen receptors α and β (αβERKO). Proc Natl Acad Sci USA 2000, 97:14737-14741
79. Kabelitz D, Wesch D, Oberg HH: Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Crit Rev Immunol 2006, 26:291-306
80. LaRosa DF, Gelman AE, Rahman AH, Zhang J, Turka LA, Walsh PT: CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells. Immunol Lett 2007, 108:183-188
81. Martin JT: Sexual dimorphism in immune function: the role of prenatal exposure to androgens and estrogens. Eur J Pharmacol 2000, 405:251-261
82. Roep BO: Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann NY Acad Sci 2007, 1103:1-10
83. D'Cruz DP, Khamashta MA, Hughes GRV: Systemic lupus erythematosus. Lancet 2007, 369:587-596
84. Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B: Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002, 109:1625-1633
85. Grimaldi CM: Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Curr Opin Rheumatol 2006, 18:456-461
86. Blank M, Mendlovic S, Fricke H, Mozes E, Talal N, Shoenfeld Y: Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naïve mice. J Rheumatol 1990, 17:311-317
87. Bhalla AK: Hormones and the immune response. Ann Rheum Dis 1989, 48:1-6
88. Ahmed SA, Verthelyi D: Antibodies to cardiolipin in normal C57BL/6J mice: induction by estrogen but not dihydrotestosterone. J Autoimmun 1993, 6:265-279
89. Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, Ohgami E, Arinobu Y, Yamaoka K, Niiro H, Shinozaki M, Hirakata H, Horiuchi T, Otsuka T, Niho Y: Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999, 42:1644-1648
90. Lit LC, Wong CK, Li EK, Tam LS, Lam CW, Lo YM: Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol 2007, 34:89-96
91. Ronnblom L, Alm GV: Effector mechanisms of autoimmunity: antibodies and immune complexes. The Autoimmune Diseases, ed 4. Edited by Rose NR, Mackay IR. St. Louis, Elsevier Academic Press, 2006, pp 203-215
92. Verthelyi D, Petri M, Ylamus M, Klinman DM: Disassociation of sex hormone levels and cytokine production in SLE patients. Lupus 2001, 10:352-358
93. Wang Y, Meng J, Wang X, Liu S, Shu Q, Gao L, Ju Y, Zhang L, Sun W, Ma C: Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol 2007, 67:63-70
94. Subramanian S, Tovey M, Afentoulis M, Krogstad A, Vandenbark AA, Offner H: Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta. Clin Immunol 2005, 115:162-172
95. Nielsen RH, Christiansen C, Stolina M, Karsdal MA: Oestrogen exhibits type II collagen protective effects and attenuates collagen-inducted arthritis in rats. Clin Exp Immunol 2008, 152:21-27
96. Jansson L, Holmdahl R: Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998, 47:290-301
97. Bretano F, Ospelt C, Stanczyk J, Gay RE, Gay S, Kyburz D: Abundant expression of the IL-23 subunit p19, but low levels of bioactive IL-23 in the rheumatoid synovium. Ann Rheum Dis 2008, DOI: 10.1136/ard.2007.082081
98. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi JI, Kaibara N, Hori A, Iwamoto Y, Yoshikai Y: Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 2007, DOI: 10.1136/ard.2007.080341
99. Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmidt M, Cutolo M, Straub RH: Increased estrogen formation and estrogen to androgen ration in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2003, 30:2597-2605
100. Olsen NJ, Kovacs WJ: Hormones, pregnancy, and rheumatoid arthritis. J Gend Specif Med 2002, 5:28-37
101. Fairweather D, Rose NR: Type I diabetes: virus infection or autoimmune disease? Nat Immunol 2002, 3:338-340
102. Fujinami RS, von Herrath MG, Christen U, Whitton JL: Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006, 19:80-94
103. Lu FX, Ma Z, Moser S, Evans TG, Miller CJ: Effects of ovarian steroids on immunoglobulin-secreting cell function in healthy women. Clin Diagn Lab Immunol 2003, 10:944-949
104. Lassmann H, Bruck W, Lucchinetti C: Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001, 7:115-121
105. Bebo Jr BF, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, Offner H: Low dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 2001, 166:2080-2089
106. Polanczyk MJ, Hopke C, Vandenbark AA, Offner H: Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Intern Immunol 2007, 19:337-343
107. Panitch HS, Hirsch RL, Haley AS, Johnson KP: Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987, 1:893-895
108. Langer-Gould A, Garren H, Slansky A, Ruiz PJ, Steinman L: Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: evidence for a suppressive pregnancy-related serum factor. J Immunol 2002, 169:1084-1091
109. Okayasu I, Kong YM, Rose NR: Effect of castration and sex hormones on experimental autoimmune thyroiditis. Clin Immunol Immunopathol 1981, 20:240-245
110. Liu PY, Death AK, Handelsman DJ: Androgens and cardiovascular disease. Endocr Rev 2003, 24:313-340
111. Schoub BD, Johnson S, McAnerney JM, Dos Santos IL, Klaassen KI: Epidemic Coxsackie B virus infection in Johannesburg. S Afr J Hyg (Lond) 1985, 95:447-455
112. Dechkum N, Pangsawan Y, Jayavasu C, Saguanwongse S: Cox-sackie B virus infection and myopericarditis in Thailand, 1987-1989. Southeast Asian J Trop Med Public Health 1998, 29:273-276
113. Fabre A, Sheppard MN: Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart 2006, 92:316-320
114. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U: T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006, 203:2009-2019
115. Valaperti A, Marty RR, Kania G, Germano D, Mauermann N, Dirnhofer S, Leimenstoll B, Blyszczuk P, Dong C, Mueller C, Hunziker L, Eriksson U: CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008, 180:2686-2695
116. Lima AP, Lunardi LO, Rosa e Silva AAM: Effects of castration and testosterone replacement on peritoneal histamine concentration and lung histamine concentration in pubertal male rats. J Endocrinol 2000, 167:71-75
117. Mahoney PM, Hurst PR, McLeod BJ, McConnell MA, Thompson EG: Effect of estradiol treatment on mast cell populations and microflora in the vaginal cul-de-sac of seasonally anestrous brushtail possums (Trichosurus vulpecula). Reproduction 2003, 125:733-741
118. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. J Am Med Assoc 2007, 297:1465-1477